Skip to main content
TipRanks
Go Ultimate75% OFF

Ultragenyx Pharmaceutical (RARE) Ownership - Who Owns Ultragenyx Pharmaceutical?

1,316 Followers

Ultragenyx Pharmaceutical (RARE) Ownership Overview

The ownership structure of Ultragenyx Pharmaceutical (RARE) stock is a mix of institutional, retail, and individual investors. Approximately 88.46% of the company’s stock is owned by Institutional Investors, 3.81% is owned by Insiders, and 7.73% is owned by Public Companies and Individual Investors.

Institutional holdings as of (latest 13F reporting period).

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue
Oct 18, 2026Howard Horn$107,898
Sep 14, 2026Theodore Alan Huizenga$17,410
Sep 07, 2026Theodore Alan Huizenga$2,252
Aug 03, 2026Howard Horn$117,024

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue
Sep 30, 2026Graham Capital Management, L.p.$257,434
Sep 30, 2026Bridgewater Associates, Lp$857,492
Sep 30, 2026Woodline Partners Lp$6,914,341
Sep 30, 2026 $171,835,781

Top Shareholders

RARE top shareholders
Holder# of SharesType% HoldingValue
BlackRock, Inc.11,432,853Institution11.22%181,782,363
Vanguard8,443,338Institution8.28%134,249,074
Vanguard Index Funds7,497,774Institution7.36%119,214,607
Spdr5,856,888Institution5.75%93,124,519
Ishares4,720,467Institution4.63%75,055,425
Frank Sands3,158,368Institution3.10%50,218,051
Emil Kakkis2,894,724Insider2.84%46,026,112
Felix Baker2,772,692Institution2.72%44,085,803
Vanguard Horizon Funds1,551,402Institution1.52%24,667,292
Fidelity Salem Street Trust1,190,194Institution1.17%18,924,085

Top Mutual Fund Holders

RARE top mutual fund holders
Holder# of SharesType% HoldingValue
Vanguard Index Funds7,497,774Institution7.36%119,214,607
Vanguard Horizon Funds1,551,402Institution1.52%24,667,292
Fidelity Salem Street Trust1,190,194Institution1.17%18,924,085
Fidelity Concord Street Trust999,015Institution0.98%15,884,339
Aqr Funds901,932Institution0.88%14,340,719
Vanguard Explorer Fund821,986Institution0.81%13,069,577
Vanguard Scottsdale Funds659,758Institution0.65%10,490,152
Tiaa-cref Funds638,534Institution0.63%10,152,691
Touchstone Funds Group Trust611,950Institution0.60%9,730,005
Blackrock Funds551,135Institution0.54%8,763,047

Top ETF Holders

RARE top ETF holders
Holder# of SharesType% HoldingValue
SPDR S&P BIOTECH ETF, XBI ETF5,344,791Institution5.24%85,944,239
iShares Russell 2000 ETF, IWM ETF2,514,993Institution2.47%40,441,087
Vanguard Total Stock Market ETF, VTI ETF2,343,906Institution2.30%37,736,887
Vanguard Small-Cap ETF, VB ETF2,095,300Institution2.06%33,734,330
Vanguard Small-Cap Growth ETF, VBK ETF1,176,046Institution1.15%18,934,341
Vanguard Extended Market ETF, VXF ETF1,122,434Institution1.10%18,071,187
iShares Biotechnology ETF, IBB ETF691,545Institution0.68%10,995,566
Vanguard Russell 2000 ETF, VTWO ETF568,502Institution0.56%9,152,882
Schwab U.S. Small-Cap ETF, SCHA ETF524,756Institution0.51%8,438,076
iShares Russell 2000 Value ETF, IWN ETF504,689Institution0.50%8,024,555

FAQ

Who Owns Ultragenyx Pharmaceutical (RARE)?
According to the latest TipRanks data (13F holdings as of September 30, 2026), approximately 88.46% of the company's stock is held by institutional investors, 3.81% is held by insiders, and 7.73% is held by public companies and individual investors.
What percentage of Ultragenyx Pharmaceutical (RARE) stock is held by institutional investors?
According to the latest TipRanks data (13F holdings as of September 30, 2026), approximately 88.46% of Ultragenyx Pharmaceutical (RARE) stock is held by institutional investors: 20.39% by mutual funds, 20.79% by ETFs and 47.28% by other institutional investors.
What percentage of Ultragenyx Pharmaceutical (RARE) stock is held by retail investors?
According to the latest TipRanks data (13F holdings as of September 30, 2026), approximately 7.73% of Ultragenyx Pharmaceutical (RARE) stock is held by public companies and individual investors.
Who owns the most shares of Ultragenyx Pharmaceutical (RARE)?
BlackRock, Inc. owns the most shares of Ultragenyx Pharmaceutical (RARE).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.